HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Failure of endotoxin-free superoxide dismutase to reduce some paw edemas and adjuvant arthritis in rats.

AbstractOBJECTIVE AND DESIGN:
To elucidate whether superoxide anion plays a major role in inflammation models in rats. Endotoxin-free CuZn superoxide (SOD) was used in the present study, because we had shown previously that even a trace of endotoxin contamination of SOD would carry anti-inflammatory effects.
MATERIAL AND TREATMENT:
Male rats were treated with saline (n=8-10), recombinant human SOD (n=8-10), and dexamethasone or indomethacin (n=8-10).
METHODS:
Foot volume was determined by mercury displacement.
RESULTS:
Two administrations of SOD (5 and 50 mg/kg), 2 h and just before irritant injection, had no effect on rat paw edema induced by phorbol, zymosan or carrageenan. Two administrations of dexamethasone (1 mg/kg) or indomethacin (3 mg/kg), 2 h and just before irritation, inhibited paw edema significantly (p<0.05). Administration of SOD (10 mg/kg) once daily for 3 weeks from the day of mycobacterium injection had no effect on injected paw swelling and non-injected paw swelling 7, 14, 21 days after irritation. Indomethacin (2 mg/kg) once daily for 3 weeks inhibited this arthritis significantly (p < 0.05).
CONCLUSIONS:
Superoxide anion may not play a major role in the genesis of inflammation in these rat inflammation models, and endotoxin-like contaminants may have contributed to some protective effects of SOD administration in previous studies.
AuthorsM Iida, K Saito
JournalInflammation research : official journal of the European Histamine Research Society ... [et al.] (Inflamm Res) Vol. 48 Issue 2 Pg. 63-6 (Feb 1999) ISSN: 1023-3830 [Print] Switzerland
PMID10202990 (Publication Type: Journal Article)
Chemical References
  • Endotoxins
  • Recombinant Proteins
  • Superoxide Dismutase
Topics
  • Animals
  • Arthritis, Experimental (drug therapy)
  • Edema (drug therapy)
  • Endotoxins (therapeutic use)
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins (therapeutic use)
  • Superoxide Dismutase (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: